Mahalevo Information
Mahalevo is a commercial drug that is prescribed in the form of Infusion, Tablet, Syrup. Urinary Tract Infection, Prostatitis, Pneumonia are some of its major therapeutic uses. Mahalevo also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Mahalevo. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Some other side effects of Mahalevo have been listed ahead. These side effects of Mahalevo are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Mahalevo has a Moderate effect for pregnant women and Severe effect on lactating mothers. It is important to know if Mahalevo has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Mahalevo related warnings section.
Mahalevo can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Mahalevo in conditions like Coronary Artery Disease (CAD), Heart Disease, Myasthenia Gravis (MG). The section on Mahalevo contraindications lists all such conditions.
Additionally, Mahalevo may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Mahalevo is considered not safe while driving, and is not addictive.
Mahalevo Benefits & Uses
Mahalevo is used to treat the following -
Main Benefits
- Urinary Tract Infection (Read More - Home remedies for UTI)
- Prostatitis
- Pneumonia
Other Benefits
- Sinusitis (Read More - Home remedies for sinusitis)
- Skin Infections (Read More - From Turmeric to Aloe Vera : How to Manage Skin Infections with Home Remedies)
- Bronchitis (Read More - How to Treat Bronchitis at Home: Simple and Effective Remedies)
- Plague
- Corneal Ulcer
- Conjunctivitis (Read More - Say Goodbye to Pink Eye: Best At-Home Treatments for Conjunctivitis)
Mahalevo Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Mahalevo Side Effects
Based on research, the following side effects have been observed when Mahalevo is used -
Severe
- Diarrhoea
- Fever (Read More - Home remedies for fever)
- पेट दर्द
- Confusion
- Headache
Moderate
- Constipation (Read More - Home remedies for constipation)
- Gastritis (Read More - How to Cure Bloating in the Stomach: Diet Tips and Home Remedies)
Mild
- Nausea or vomiting
- Insomnia
- Dizziness (Read More - Home Remedies for Dizziness: Quick Tips for Instant Relief)
- Urticaria
- Rash
Mahalevo Related Warnings
-
Is the use of Mahalevo safe for pregnant women?
Mahalevo may have some side effects during pregnancy. Pregnant women should discontinue the use of Mahalevo, and talk to their doctor, if they notice any discomfort.
Moderate -
Is the use of Mahalevo safe during breastfeeding?
Taking Mahalevo may lead to serious side effects if you are breastfeeding. Mahalevo should not be taken by breastfeeding women unless prescribed by the doctor.
Severe -
What is the effect of Mahalevo on the Kidneys?
Mahalevo may have mild side effects on the kidneys.
Mild -
What is the effect of Mahalevo on the Liver?
Mahalevo is not harmful for the liver.
Safe -
What is the effect of Mahalevo on the Heart?
Using Mahalevo does not have any harmful effects on the heart.
Safe
Severe Interaction of Mahalevo with Other Drugs
Mahalevo should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mahalevo Contraindications
If you are suffering from any of the following diseases, you should not take Mahalevo unless your doctor advises you to do so -
- Ulcerative Colitis
- Diabetes
- Coronary Artery Disease (CAD)
- Heart Disease
- Calcium Deficiency
- Potassium Deficiency
- Myasthenia Gravis
- Liver Disease
Frequently asked Questions about Mahalevo
-
Is this Mahalevo habit forming or addictive?
Mahalevo is not addictive in nature.
No -
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Mahalevo as you may feel sleepy.
Dangerous -
Is it safe?
Yes, Mahalevo is safe but you must consult your doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
Mahalevo is unable to treat or cure mental disorders.
No
Mahalevo Interactions with Food and Alcohol
-
Interaction between Food and Mahalevo
Mahalevo may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Mild -
Interaction between Alcohol and Mahalevo
Side effects of drinking alcohol and taking Mahalevo at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
Mild
See all substitutes for Mahalevo
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levaquin® (levofloxacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1399
